Company / Revenue per Share
OCULAR THERAPEUTIX, INC Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.33
FY2025
5-year range
$0.06 / $0.76
FY2021-FY2025
Trend
-40.6%
vs FY2024
Sector context
#122 of 154
Health Care
What the data says
OCULAR THERAPEUTIX, INC's revenue per share of $0.33 is lower than 79% of companies in the Health Care sector (FY2025). Revenue per Share has fluctuated over the past 10 years, ranging from $0.05 in FY2019 to $0.76 in FY2023.
Based on SEC 10-K filings.
0.33 in FY2025 with a 5-year CAGR of +31.4%.
Declined from $0.76 to $0.33 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +13.2%
- 5-Year CAGR
- +31.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 154This company $0.33 Sector average $10.35
▼
-96.8% below sector average
Key checks
Key Insights
- In FY2025, revenue per share decreased 40.6% year-over-year.
- Ranks #122 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2023.
- Lowest revenue per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.25 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.33 | -40.6% |
| FY2024 | $0.55 | -26.8% |
| FY2023 | $0.76 | +233.8% |
| FY2022 | $0.23 | +307.8% |
| FY2021 | $0.06 | -33.8% |
| FY2020 | $0.08 | +81.3% |
| FY2019 | $0.05 | -31.0% |
| FY2018 | $0.07 | -12.7% |
| FY2017 | $0.08 | +0.8% |
| FY2016 | $0.08 | +110.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026